Sirio Pharma Co., Ltd. (300791.SZ)
CNY 25.06
(-0.44%)
CNY 25.06
(-0.44%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 834.75 Million CNY | 247.82% |
| 2022 | -564.69 Million CNY | -455.78% |
| 2021 | 158.72 Million CNY | 187.21% |
| 2020 | -181.99 Million CNY | 38.44% |
| 2019 | -295.62 Million CNY | -182.47% |
| 2018 | 358.47 Million CNY | 39.01% |
| 2017 | 257.87 Million CNY | 117.79% |
| 2016 | 118.4 Million CNY | -41.77% |
| 2015 | 203.34 Million CNY | 79.92% |
| 2014 | 113.01 Million CNY | 69.69% |
| 2013 | 66.6 Million CNY | -35.2% |
| 2012 | 102.78 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1 Billion CNY | -3.54% |
| 2024 Q3 | 631.59 Million CNY | -11.3% |
| 2024 Q1 | 1.04 Billion CNY | 24.89% |
| 2023 FY | 834.75 Million CNY | 247.82% |
| 2023 Q4 | 834.75 Million CNY | -0.8% |
| 2023 Q3 | 841.5 Million CNY | 4.76% |
| 2023 Q2 | 803.26 Million CNY | 5.43% |
| 2023 Q1 | 761.88 Million CNY | 234.92% |
| 2022 FY | -564.69 Million CNY | -455.78% |
| 2022 Q4 | -564.69 Million CNY | -449.73% |
| 2022 Q3 | -102.72 Million CNY | -168.08% |
| 2022 Q2 | 150.88 Million CNY | -33.01% |
| 2022 Q1 | 225.23 Million CNY | 41.91% |
| 2021 Q4 | 158.72 Million CNY | 196.29% |
| 2021 Q2 | -320.7 Million CNY | -118.21% |
| 2021 FY | 158.72 Million CNY | 187.21% |
| 2021 Q1 | -146.97 Million CNY | 19.24% |
| 2021 Q3 | -164.82 Million CNY | 48.6% |
| 2020 Q2 | -376.1 Million CNY | 7.63% |
| 2020 Q3 | -397.47 Million CNY | -5.68% |
| 2020 Q1 | -407.15 Million CNY | -37.72% |
| 2020 Q4 | -181.99 Million CNY | 54.21% |
| 2020 FY | -181.99 Million CNY | 38.44% |
| 2019 Q3 | -751.67 Million CNY | -366.75% |
| 2019 FY | -295.62 Million CNY | -182.47% |
| 2019 Q4 | -295.62 Million CNY | 60.67% |
| 2019 Q2 | 281.78 Million CNY | 289.35% |
| 2019 Q1 | 72.37 Million CNY | -79.81% |
| 2018 FY | 358.47 Million CNY | 39.01% |
| 2018 Q2 | 337.47 Million CNY | 0.0% |
| 2018 Q4 | 358.47 Million CNY | 0.0% |
| 2017 FY | 257.87 Million CNY | 117.79% |
| 2016 FY | 118.4 Million CNY | -41.77% |
| 2015 Q3 | 222.88 Million CNY | 0.0% |
| 2015 Q4 | 203.34 Million CNY | -8.77% |
| 2015 FY | 203.34 Million CNY | 79.92% |
| 2014 FY | 113.01 Million CNY | 69.69% |
| 2013 FY | 66.6 Million CNY | -35.2% |
| 2012 FY | 102.78 Million CNY | 0.0% |